Insulet Corporation

PODDNASDAQ • USD
ThemeMedical Devices & HealthTech›Wearable Medical Devices
142.43 USD
↘ 5.70 (3.85%)AT CLOSE (11:59 AM EDT)
141.98
↘ 0.46 (0.32%)
POST MARKET (AS OF 07:47 PM EDT)
Post Market
AS OF 07:47 PM EDT
141.98
↘ 0.46 (0.32%)
🔴Market: CLOSED
Open?$145.65
High?$147.23
Low?$141.06
Prev. Close?$148.13
Volume?1.1M
Avg. Volume?1.6M
VWAP?$142.92
Rel. Volume?0.68x
Bid / Ask
Bid?$136.56 × 100
Ask?$150.56 × 100
Spread?$14.00
Midpoint?$143.56
Valuation & Ratios
Market Cap?10.3B
Shares Out?69.3M
Float?69.0M
Float %?99.6%
P/E Ratio?33.88
P/B Ratio?7.88
EPS?$4.37
Dividend?0.00%
Ex-Dividend?N/A

PODD is currently priced at $142.41. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, exceptional Return on Equity (23.3%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, PODD trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Jun 2, 2026.

News
Profile
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Themes
Medical Devices & HealthTech›Wearable Medical DevicesDigital Health & Telemedicine›Remote Patient Monitoring
Employees
5.4K
Market Cap
10.3B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.insulet.com
Listed
2007-05-15
Address
100 NAGOG PARK
ACTON, MA 01720
Phone: 978-600-7000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
99
Momentum?
73
Short Sent.?
75
Piotroski F-Score?4/9Mixed
Altman Z-Score?5.77Safe
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestLow
Short % of Float?4.37%Low
Short Interest?3.0M
Days to Cover?1.6
Free Float69.0M
Avg Daily Volume1.9M
Settlement Date2026-05-15
Financial Health
Current Ratio?2.49Strong
Quick Ratio?1.81Adequate
Cash Ratio?0.70Adequate
Debt/Equity?0.73Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
61/100
P/E?
Peers
100
S&P
25
33.9PRICEY▾
P/B?
Peers
100
S&P
24
7.88FAIR▾
P/S?
Peers
100
S&P
43
3.54FAIR▾
P/FCF?
Peers
100
S&P
38
25.7FAIR▾
EV/EBITDA?
Peers
100
S&P
34
17.8FAIR▾
EV/Sales?
Peers
100
S&P
51
3.70FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
72
23.3%STRONG▾
ROA?
Peers
50
S&P
75
10.1%STRONG▾
Cash Flow & Enterprise
FCF?$399.9M
Enterprise Value?$10.7B
Fundamentals ratios updated end of day
MarketsMoversWatchlist